Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium carbonate for cannabis withdrawal in cannabis dependence
ACTRN12610000182099Phase 3Completed
- Sponsor
- Brain and Mind Centre
- Start
- Dec 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cannabis use disorder (CUD) comparing Lithium carbonate with Placebo (2 arms). Primary endpoints: Severity of cannabis withdrawal, Detoxification completion rates and 1 more. Started Dec 2010; status: completed.
02
Drugs
lithium carbonate
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on ACTRN12610000182099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000182099.